Sleep Disordered Breathing, APOE, and Lipid Metabolism
Other study identifiers
Sponsor study identifier
Secondary identifiers
NIH
observational
N/A
0 countries
N/A
Study Start
September 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2007
Actual (reported)Study Completion
April 2007
Actual (reported)Brief Summary
To examine the relationship between obstructive sleep apnea and lipid metabolism.
Registry Overview
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
- Recruitment status
- completed
- Reported enrollment (type unavailable)
- Not reported
- Study completion date
April 2007
Actual (reported)- Listed locations
- 0 countries · 0 sites
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
Study Start
September 2002
Date type not reportedThis date has not been verified as actual or estimated.
First Submitted
September 30, 2002
Actual (reported)First Posted
October 1, 2002
Actual (reported)Primary Completion
April 2007
Actual (reported)Study Completion
April 2007
Actual (reported)
- Last Updated
- March 5, 2014
- Status Verified
- March 2014
- Last Update Submitted
- March 4, 2014
Conditions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Stanford UniversityOtherlead
- National Heart, Lung, and Blood Institute (NHLBI)NIHcollaborator
Related Publications (3)
Lin L, Finn L, Zhang J, Young T, Mignot E. Angiotensin-converting enzyme, sleep-disordered breathing, and hypertension. Am J Respir Crit Care Med. 2004 Dec 15;170(12):1349-53. doi: 10.1164/rccm.200405-616OC. Epub 2004 Sep 24.
PMID: 15447944BACKGROUNDGottlieb DJ, DeStefano AL, Foley DJ, Mignot E, Redline S, Givelber RJ, Young T. APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study. Neurology. 2004 Aug 24;63(4):664-8. doi: 10.1212/01.wnl.0000134671.99649.32.
PMID: 15326239BACKGROUNDTaheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004 Dec;1(3):e62. doi: 10.1371/journal.pmed.0010062. Epub 2004 Dec 7.
PMID: 15602591BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
Emmanuel Mignot
Stanford University
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 30, 2002
First Posted
October 1, 2002
Study Start
September 2002
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
April 2007
Actual (reported)Study Completion
April 2007
Actual (reported)Last Updated
March 5, 2014
Record last verified: 2014-03
Source record
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
- Registry identifier
- NCT00046670
- Data provider
- ClinicalTrials.gov
- Source updated
- 2014-03-05
- Normalization version
- ctgov-legacy-1
Source retrieved: